Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Aethlon Medical (AEMD) Shares Issued (2016 - 2025)

Aethlon Medical filings provide 14 years of Shares Issued readings, the most recent being -$3.3 million for Q1 2025.

  • On a quarterly basis, Shares Issued fell 161.61% to -$3.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.1 million, a 205494100.0% increase, with the full-year FY2025 number at $2.1 million, changed N/A from a year prior.
  • Shares Issued hit -$3.3 million in Q1 2025 for Aethlon Medical, down from $1.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $17.5 million in Q2 2021 to a low of -$3.3 million in Q1 2025.
  • Median Shares Issued over the past 5 years was $1.1 million (2023), compared with a mean of $3.2 million.
  • Biggest five-year swings in Shares Issued: soared 888.95% in 2024 and later tumbled 161.61% in 2025.
  • Aethlon Medical's Shares Issued stood at $17.5 million in 2021, then crashed by 52.41% to $8.3 million in 2022, then plummeted by 97.76% to $186501.0 in 2023, then soared by 888.95% to $1.8 million in 2024, then crashed by 280.51% to -$3.3 million in 2025.
  • The last three reported values for Shares Issued were -$3.3 million (Q1 2025), $1.8 million (Q4 2024), and $3.5 million (Q2 2024) per Business Quant data.